James Testa is currently the Associate Director of Preclinical R&D at Celldex, where they oversee cell therapy analytical development and testing for internal clients. Previously, at Janssen Pharmaceutical Companies of Johnson & Johnson, they served as a Senior Scientist and led cross-functional teams in large molecule biotherapeutic drug development, particularly in oncology. James earned a Ph.D. in Immunology from Thomas Jefferson University and has extensive experience in cancer immunotherapy and viral infections. Their career includes roles in various research settings, focusing on the discovery and characterization of immune modulators and therapeutic targets.
This person is not in any teams
This person is not in any offices